Encompass Health Co. (NYSE:EHC) Shares Acquired by State Street Corp

State Street Corp increased its position in Encompass Health Co. (NYSE:EHC - Free Report) by 0.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,025,769 shares of the company's stock after buying an additional 21,329 shares during the period. State Street Corp owned about 3.00% of Encompass Health worth $292,410,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Point72 Asset Management L.P. boosted its holdings in Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock valued at $83,990,000 after acquiring an additional 835,135 shares during the last quarter. Magnetar Financial LLC raised its holdings in shares of Encompass Health by 1,176.6% in the 2nd quarter. Magnetar Financial LLC now owns 744,836 shares of the company's stock worth $63,899,000 after purchasing an additional 814,018 shares during the period. Thrivent Financial for Lutherans grew its holdings in shares of Encompass Health by 2,302.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 603,558 shares of the company's stock worth $51,780,000 after purchasing an additional 578,438 shares during the period. AQR Capital Management LLC increased its position in Encompass Health by 213.3% during the 2nd quarter. AQR Capital Management LLC now owns 207,202 shares of the company's stock worth $17,776,000 after purchasing an additional 141,075 shares in the last quarter. Finally, Cubist Systematic Strategies LLC lifted its position in Encompass Health by 762.4% during the second quarter. Cubist Systematic Strategies LLC now owns 83,347 shares of the company's stock valued at $7,150,000 after buying an additional 73,683 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Encompass Health Stock Up 0.4 %

Shares of EHC stock traded up $0.41 during mid-day trading on Wednesday, reaching $101.70. 524,692 shares of the company were exchanged, compared to its average volume of 638,278. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The business's 50 day simple moving average is $99.07 and its 200 day simple moving average is $92.29. The company has a market capitalization of $10.25 billion, a P/E ratio of 24.47, a P/E/G ratio of 1.36 and a beta of 0.86. Encompass Health Co. has a fifty-two week low of $65.33 and a fifty-two week high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the firm earned $0.86 EPS. The company's revenue was up 11.9% on a year-over-year basis. Research analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. Encompass Health's payout ratio is 16.43%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on EHC shares. KeyCorp increased their price objective on shares of Encompass Health from $115.00 to $117.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. Truist Financial reiterated a "buy" rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. UBS Group boosted their price objective on Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a research note on Wednesday, September 25th. Royal Bank of Canada upped their target price on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Finally, Barclays raised their target price on Encompass Health from $109.00 to $116.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of "Buy" and a consensus target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.